Where does Trethera's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Trethera's 7 recorded funding rounds.

Premier Alternatives

Trethera

Sherman Oaks, CA · Founded 2015 · Privately Held (backing)

Developer of nucleotide metabolism drugs designed to provide treatment for cancer and autoimmune diseases. Trethera is based in Sherman Oaks, CA and was founded in 2015. Its last reported valuation was $13.1 million in Apr 2019. It has raised $35 million across 7 recorded rounds; the latest was a $250,000 seed round in Apr 2025.

Last reported valuation

$13.1M

Oct 2026

Priced at

—

Total raised

$35.0M

Last round

Seed Round

Apr 2025

Cap table — not yet on record

Trethera's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Trethera with a free account

·Watch Trethera: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Trethera

Where does Trethera's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Trethera's 7 recorded funding rounds.